Cite

HARVARD Citation

    DeSouza, K. et al. (2019). A Real-world Analysis of the Treatment of HER2+ Metastatic Breast Cancer (mBC) Beyond First-line HER2-directed Therapies. Clinical oncology. 31 (7), pp. e108-. [Online]. 
  
Back to record